Bright Minds Biosciences Inc
DRUG
Get informed when a big investor buys or sells
+ FollowMarket Cap$712.6M
Close$
$8.66
87.8% downside
Current Fair Value
87.8% downsideOvervalued by 87.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $712.60 Million |
|---|---|
| Enterprise Value | $404.51 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.78 |
| Beta | 0.09 |
| Outstanding Shares | 9,830,424 |
Return
| Return on Equity | -7.65% |
|---|---|
| Return on Assets | -7.59% |
| Return on Invested Capital | -11.25% |
Valuation & Multiples
| P/E Ratio | -35.04 |
|---|---|
| PEG | 66.05 |
| Price to Sales | - |
| Price to Book Ratio | 2.29 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -11.66 |
| Enterprise Value to Net Income | -18 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-1.22
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
December 17, 2026
EPS Estimate
$-1.73
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 95.82%▲ 10.90% |
|---|---|
| Total Invested | $670.28M▲ 30.17% |
| Investors Holding | 94▲ 20.00% |
ESG Score
No data